Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Science Immunology|April 17, 2026
The autoantigen TRIM21 assembles proinflammatory immune complexes after lytic cell deathEsther L Jones Evans, Benjamin Demarco, Han Cai, et al.
BMJ Open Respiratory Research|December 31, 2021
Phase 2 trial design of BMS-986278, a lysophosphatidic acid receptor 1 (LPA<sub>1</sub>) antagonist, in patients with idiopathic pulmonary fibrosis (IPF) or progressive fibrotic interstitial lung disease (PF-ILD)Tamera J Corte, Lisa Lancaster, Jeffrey J Swigris, et al.
Contemporary Clinical Trials|March 3, 2021
The FALCON program: Two phase 2b randomized, double-blind, placebo-controlled studies to assess the efficacy and safety of pegbelfermin in the treatment of patients with nonalcoholic steatohepatitis and bridging fibrosis or compensated cirrhosisManal F Abdelmalek, Edgar D Charles, Arun J Sanyal, et al.
JAMA Dermatology|July 17, 2024
Cendakimab in Patients With Moderate to Severe Atopic Dermatitis: A Randomized Clinical TrialAndrew Blauvelt, Emma Guttman-Yassky, Charles Lynde, et al.
Journal of Magnetic Resonance Imaging : JMRI|January 29, 2022
Evaluation of a PEGylated Fibroblast Growth Factor 21 Variant Using Novel Preclinical Magnetic Resonance Imaging and Magnetic Resonance Elastography in a Mouse Model of Nonalcoholic SteatohepatitisHaiying Tang, Jiahui Li, Bradley Zinker, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 23, 2023
Pegbelfermin in Patients With Nonalcoholic Steatohepatitis and Stage 3 Fibrosis (FALCON 1): A Randomized Phase 2b StudyRohit Loomba, Arun J Sanyal, Atsushi Nakajima, et al.
Nature Immunology|August 29, 2025
Single-cell atlas of human liver and blood immune cells across fatty liver disease stages reveals distinct signatures linked to liver dysfunction and fibrogenesisOwen P Martin, Michael S Wallace, Christopher Oetheimer, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 23, 2023
Pegbelfermin in Patients With Nonalcoholic Steatohepatitis and Compensated Cirrhosis (FALCON 2): A Randomized Phase 2b StudyManal F Abdelmalek, Arun J Sanyal, Atsushi Nakajima, et al.
Nature Communications|June 24, 2016
MAIT cells are activated during human viral infectionsBonnie van Wilgenburg, Iris Scherwitzl, Edward C Hutchinson, et al.
Cell Metabolism|November 2, 2022
MGAT2 inhibitor decreases liver fibrosis and inflammation in murine NASH models and reduces body weight in human adults with obesityDong Cheng, Bradley A Zinker, Yi Luo, et al.
Pageof 6